Cipher Pharmaceuticals Inc. (TSE:CPH) Director Sells C$47,215.00 in Stock

Cipher Pharmaceuticals Inc. (TSE:CPH - Get Free Report) (NASDAQ:CPHR) Director Harold Morton Wolkin sold 3,500 shares of Cipher Pharmaceuticals stock in a transaction on Monday, March 24th. The shares were sold at an average price of C$13.49, for a total value of C$47,215.00.

Cipher Pharmaceuticals Stock Down 3.7 %

CPH opened at C$12.65 on Tuesday. Cipher Pharmaceuticals Inc. has a 12 month low of C$7.90 and a 12 month high of C$19.69. The business has a 50-day moving average of C$12.88 and a two-hundred day moving average of C$14.42. The company has a debt-to-equity ratio of 41.22, a current ratio of 2.00 and a quick ratio of 2.67. The stock has a market capitalization of C$227.11 million, a price-to-earnings ratio of 13.97 and a beta of 1.20.

Cipher Pharmaceuticals Company Profile

(Get Free Report)

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.

Insider Buying or Selling at Cipher Pharmaceuticals?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Cipher Pharmaceuticals and related companies.
More From MarketBeat
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles